trending Market Intelligence /marketintelligence/en/news-insights/trending/ZD8AkZ4ZuxL--_qb7cCP0g2 content esgSubNav
In This List

Abattis Bioceuticals names CFO/COO, director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Abattis Bioceuticals names CFO/COO, director

Abattis Bioceuticals Corp. named Kent McParland CFO and COO.

McParland replaces CFO David Whitney and COO Rene David.

Additionally, the Canadian company appointed Wolfgang Richter to its board.

Richter previously served as a director at the company's former unit Northern Vine Canada Inc.

Abattis is a life sciences and biotechnology company focusing on cannabis technologies and biotechnology services for the legal cannabis industry in Canada.